Literature DB >> 24899174

Quantitative proteomic analysis of the influenza A virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor.

Kazuki Tawaratsumida1, Van Phan1, Eike R Hrincius1, Anthony A High2, Richard Webby1, Vanessa Redecke1, Hans Häcker3.   

Abstract

UNLABELLED: Influenza A virus (IAV) replication depends on the interaction of virus proteins with host factors. The viral nonstructural protein 1 (NS1) is essential in this process by targeting diverse cellular functions, including mRNA splicing and translation, cell survival, and immune defense, in particular the type I interferon (IFN-I) response. In order to identify host proteins targeted by NS1, we established a replication-competent recombinant IAV that expresses epitope-tagged forms of NS1 and NS2, which are encoded by the same gene segment, allowing purification of NS proteins during natural cell infection and analysis of interacting proteins by quantitative mass spectrometry. We identified known NS1- and NS2-interacting proteins but also uncharacterized proteins, including PACT, an important cofactor for the IFN-I response triggered by the viral RNA-sensor RIG-I. We show here that NS1 binds PACT during virus replication and blocks PACT/RIG-I-mediated activation of IFN-I, which represents a critical event for the host defense. Protein interaction and interference with IFN-I activation depended on the functional integrity of the highly conserved RNA binding domain of NS1. A mutant virus with deletion of NS1 induced high levels of IFN-I in control cells, as expected; in contrast, shRNA-mediated knockdown of PACT compromised IFN-I activation by the mutant virus, but not wild-type virus, a finding consistent with the interpretation that PACT (i) is essential for IAV recognition and (ii) is functionally compromised by NS1. Together, our data describe a novel approach to identify virus-host protein interactions and demonstrate that NS1 interferes with PACT, whose function is critical for robust IFN-I production. IMPORTANCE: Influenza A virus (IAV) is an important human pathogen that is responsible for annual epidemics and occasional devastating pandemics. Viral replication and pathogenicity depends on the interference of viral factors with components of the host defense system, particularly the type I interferon (IFN-I) response. The viral NS1 protein is known to counteract virus recognition and IFN-I production, but the molecular mechanism is only partially defined. We used a novel proteomic approach to identify host proteins that are bound by NS1 during virus replication and identified the protein PACT, which had previously been shown to be involved in virus-mediated IFN-I activation. We find that NS1 prevents PACT from interacting with an essential component of the virus recognition pathway, RIG-I, thereby disabling efficient IFN-I production. These observations provide an important piece of information on how IAV efficiently counteracts the host immune defense.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24899174      PMCID: PMC4136281          DOI: 10.1128/JVI.00830-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses.

Authors:  Friedemann Weber; Valentina Wagner; Simon B Rasmussen; Rune Hartmann; Søren R Paludan
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 2.  Mass spectrometry-based proteomics turns quantitative.

Authors:  Shao-En Ong; Matthias Mann
Journal:  Nat Chem Biol       Date:  2005-10       Impact factor: 15.040

3.  Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase.

Authors:  S L Tan; M G Katze
Journal:  J Interferon Cytokine Res       Date:  1998-09       Impact factor: 2.607

4.  PACT, a protein activator of the interferon-induced protein kinase, PKR.

Authors:  R C Patel; G C Sen
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

5.  The generation of recombinant influenza A viruses expressing a PB2 fusion protein requires the conservation of a packaging signal overlapping the coding and noncoding regions at the 5' end of the PB2 segment.

Authors:  Emmanuel Dos Santos Afonso; Nicolas Escriou; India Leclercq; Sylvie van der Werf; Nadia Naffakh
Journal:  Virology       Date:  2005-10-10       Impact factor: 3.616

Review 6.  Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase.

Authors:  M Gale; M G Katze
Journal:  Pharmacol Ther       Date:  1998-04       Impact factor: 12.310

7.  The role of PACT in the RNA silencing pathway.

Authors:  Yoontae Lee; Inha Hur; Seong-Yeon Park; Young-Kook Kim; Mi Ra Suh; V Narry Kim
Journal:  EMBO J       Date:  2006-01-19       Impact factor: 11.598

8.  Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7.

Authors:  I Marié; J E Durbin; D E Levy
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

9.  Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems.

Authors:  A García-Sastre; A Egorov; D Matassov; S Brandt; D E Levy; J E Durbin; P Palese; T Muster
Journal:  Virology       Date:  1998-12-20       Impact factor: 3.616

10.  Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase.

Authors:  Y L Yang; L F Reis; J Pavlovic; A Aguzzi; R Schäfer; A Kumar; B R Williams; M Aguet; C Weissmann
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  32 in total

1.  Molecular basis of mammalian transmissibility of avian H1N1 influenza viruses and their pandemic potential.

Authors:  Mark Zanin; Sook-San Wong; Subrata Barman; Challika Kaewborisuth; Peter Vogel; Adam Rubrum; Daniel Darnell; Atanaska Marinova-Petkova; Scott Krauss; Richard J Webby; Robert G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

2.  Arenaviral Nucleoproteins Suppress PACT-Induced Augmentation of RIG-I Function To Inhibit Type I Interferon Production.

Authors:  Yuying Liang; Hinh Ly; Junjie Shao; Qinfeng Huang; Xiaoying Liu; Da Di
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

3.  DYT-PRKRA Mutation P222L Enhances PACT's Stimulatory Activity on Type I Interferon Induction.

Authors:  Lauren S Vaughn; Kenneth Frederick; Samuel B Burnett; Nutan Sharma; D Cristopher Bragg; Sarah Camargos; Francisco Cardoso; Rekha C Patel
Journal:  Biomolecules       Date:  2022-05-17

4.  PACT- and RIG-I-Dependent Activation of Type I Interferon Production by a Defective Interfering RNA Derived from Measles Virus Vaccine.

Authors:  Ting-Hin Ho; Chun Kew; Pak-Yin Lui; Chi-Ping Chan; Takashi Satoh; Shizuo Akira; Dong-Yan Jin; Kin-Hang Kok
Journal:  J Virol       Date:  2015-11-25       Impact factor: 5.103

5.  Identification of Toll-like receptor signaling inhibitors based on selective activation of hierarchically acting signaling proteins.

Authors:  Sirish K Ippagunta; Julie A Pollock; Naina Sharma; Wenwei Lin; Taosheng Chen; Kazuki Tawaratsumida; Anthony A High; Jaeki Min; Yizhe Chen; R Kiplin Guy; Vanessa Redecke; John A Katzenellenbogen; Hans Häcker
Journal:  Sci Signal       Date:  2018-08-14       Impact factor: 8.192

6.  PACT Facilitates RNA-Induced Activation of MDA5 by Promoting MDA5 Oligomerization.

Authors:  Pak-Yin Lui; Lok-Yin Roy Wong; Ting-Hin Ho; Shannon Wing Ngor Au; Chi-Ping Chan; Kin-Hang Kok; Dong-Yan Jin
Journal:  J Immunol       Date:  2017-07-31       Impact factor: 5.426

Review 7.  A tale of two proteins: PACT and PKR and their roles in inflammation.

Authors:  Evelyn Chukwurah; Kenneth T Farabaugh; Bo-Jhih Guan; Parameswaran Ramakrishnan; Maria Hatzoglou
Journal:  FEBS J       Date:  2021-01-15       Impact factor: 5.622

8.  The Interaction of Influenza A NS1 and Cellular TRBP Protein Modulates the Function of RNA Interference Machinery.

Authors:  Qi Wang; Jiaxin Wang; Yan Xu; Zhe Li; Binbin Wang; Yang Li
Journal:  Front Microbiol       Date:  2022-04-26       Impact factor: 5.640

9.  Virus-host interactomics: new insights and opportunities for antiviral drug discovery.

Authors:  Benoît de Chassey; Laurène Meyniel-Schicklin; Jacky Vonderscher; Patrice André; Vincent Lotteau
Journal:  Genome Med       Date:  2014-11-29       Impact factor: 11.117

Review 10.  Mechanisms of innate immune evasion in re-emerging RNA viruses.

Authors:  Daphne Y Ma; Mehul S Suthar
Journal:  Curr Opin Virol       Date:  2015-03-09       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.